• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾透明细胞癌手术治疗的远期结果

Late results of surgical treatment of renal clear-cell carcinoma.

作者信息

Czaplicki M, Borkowski A, Wesołowski S, Kuzaka B, Walecki S, Milewski J B

出版信息

Int Urol Nephrol. 1986;18(1):37-43. doi: 10.1007/BF02082646.

DOI:10.1007/BF02082646
PMID:3721763
Abstract

Late results of surgical treatment are reported in a group of 140 patients operated for clear-cell renal carcinoma in the years 1960-1974. The mean survival time was 5.61 years for males and 6.59 years for females which is, respectively, 14.19 years and 15.39 years shorter than the mean life expectancy of their peers in the general population. The survival time of males depended in 15.7% on the age at the time of operation and in 68.7% on the tumour progression grade (T). The respective data of females were 13% and 17.6%. The 5-year survival rate was 40% and the 10-year survival rate was 28.6%.

摘要

报告了1960年至1974年间接受手术治疗的140例透明细胞肾细胞癌患者的远期结果。男性的平均生存时间为5.61年,女性为6.59年,分别比普通人群中同龄人的平均预期寿命短14.19年和15.39年。男性的生存时间15.7%取决于手术时的年龄,68.7%取决于肿瘤进展分级(T)。女性的相应数据分别为13%和17.6%。5年生存率为40%,10年生存率为28.6%。

相似文献

1
Late results of surgical treatment of renal clear-cell carcinoma.肾透明细胞癌手术治疗的远期结果
Int Urol Nephrol. 1986;18(1):37-43. doi: 10.1007/BF02082646.
2
Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended followup.肾细胞癌保肾手术后的进展与生存:104例患者的经验及长期随访
J Urol. 1990 Oct;144(4):852-7; discussion 857-8. doi: 10.1016/s0022-5347(17)39608-8.
3
Long-term survival after radical surgery for renal cell carcinoma with tumour thrombus extension into the right atrium.根治性手术治疗右心房内肿瘤栓延伸的肾细胞癌的长期生存。
BJU Int. 2013 Mar;111(3 Pt B):E59-64. doi: 10.1111/j.1464-410X.2012.11515.x. Epub 2012 Sep 18.
4
Surgical enucleation for renal cell carcinoma.肾细胞癌的手术摘除术。
J Urol. 1986 Feb;135(2):235-8. doi: 10.1016/s0022-5347(17)45595-9.
5
Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.孤立肾肾细胞癌:保留肾单位手术后并发症及预后分析
J Urol. 2002 Aug;168(2):454-9. doi: 10.1016/s0022-5347(05)64657-5.
6
Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.非透明细胞组织学类型的转移性肾细胞癌的减瘤性肾切除术。
J Urol. 2007 Nov;178(5):1896-900. doi: 10.1016/j.juro.2007.07.037. Epub 2007 Sep 17.
7
Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases.肾细胞癌根治性肾切除术:328例患者的长期结果及预后因素
Eur Urol. 1997;31(1):40-8. doi: 10.1159/000474416.
8
[Organ-preserving surgery of renal cell carcinoma. The surgical technic, results and complications].[肾细胞癌的保肾手术。手术技术、结果及并发症]
Dtsch Med Wochenschr. 1991 Jan 25;116(4):121-7. doi: 10.1055/s-2008-1063590.
9
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).复发时间是复发性肾细胞癌患者复发后癌症特异性生存的重要预测指标——来自综合多中心数据库(CORONA/SATURN-项目)的结果。
BJU Int. 2013 Nov;112(7):909-16. doi: 10.1111/bju.12246. Epub 2013 Jul 25.
10
Renal cell carcinoma with vascular invasion: Mortality and prognostic factors.伴有血管侵犯的肾细胞癌:死亡率及预后因素。
Actas Urol Esp. 2017 Mar;41(2):132-138. doi: 10.1016/j.acuro.2016.06.007. Epub 2016 Jul 25.

本文引用的文献

1
Renal cell carcinoma: long-term survival and late recurrence.肾细胞癌:长期生存与晚期复发
J Urol. 1981 Jul;126(1):17-23. doi: 10.1016/s0022-5347(17)54359-1.
2
Comparative study of actuarial survival rates in stage II and III renal cell carcinomas managed by radical nephrectomy alone or associated with formal retroperitoneal lymph node dissection.
Prog Clin Biol Res. 1982;100:489-92.
3
Experience with 204 renal cell carcinomas. Management and operative approach.204例肾细胞癌的经验。治疗与手术方法。
Eur Urol. 1983;9(3):164-6. doi: 10.1159/000474073.
4
[Can the long-term survival in cancer of the kidney in adults be improved by cellulo-lymphadenectomy?].[细胞性淋巴结清扫术能否提高成人肾癌的长期生存率?]
J Urol (Paris). 1983;89(7):507-13.
5
[Value of surgery in metastatic cancer of the kidney].[手术在肾转移性癌中的价值]
J Urol (Paris). 1983;89(7):501-5.
6
Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trial.M0期肾细胞癌根治性肾切除术中辅助使用醋酸甲羟孕酮:一项前瞻性随机试验的初步报告
Eur Urol. 1983;9(4):202-6. doi: 10.1159/000474083.
7
Renal arterial embolization in cases of renal neoplasms. Own experiences.肾肿瘤病例中的肾动脉栓塞术。个人经验。
Int Urol Nephrol. 1980;12(4):317-24. doi: 10.1007/BF02082468.
8
Current therapy for renal cell carcinoma.肾细胞癌的当前治疗方法。
J Urol. 1982 Feb;127(2):211-7. doi: 10.1016/s0022-5347(17)53706-4.
9
The results of radical nephrectomy for renal cell carcinoma.肾细胞癌根治性肾切除术的结果。
J Urol. 1969 Mar;101(3):297-301. doi: 10.1016/s0022-5347(17)62331-0.
10
[Immediate and long-term results of the surgical treatment of malignant neoplasms of the kidney].[肾脏恶性肿瘤外科治疗的近期及远期结果]
Urol Nefrol (Mosk). 1969 Nov-Dec;34(6):34-9.